Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine as adjuvant therapy in severe Graves' disease
PACTR201912487382180Completed
- Sponsor
- Alexandria University
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of azathioprine in Graves' disease and hyperthyroidism (3 arms), sponsored by Alexandria University. Primary endpoints: Rate of remission, Complete remission and 1 more. Started Apr 2017; status: completed.
02
Drugs
azathioprine
03
Conditions
Graves' diseasehyperthyroidism
Beyond the preview
Go deeper on PACTR201912487382180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201912487382180.